Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer.
Tsuchida, J., Nagahashi, M., Nakajima, M., Katsuta, E., Rashid, O. M., Qi, Q., Yan, L., Okuda, S., Takabe, K., Wakai, T. Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer. J. Surg. Res. 256:645-656(2020).
Gallincin ameliorates colitis-associated inflammation and barrier function in mice based on network pharmacology prediction.
Cui, D-J., Yang, X-L., Okuda, S., Ling, Y-W., Zhang, Z-X., Qi, L., Yuan, W-Q., Yan, F. Gallincin ameliorates colitis-associated inflammation and barrier function in mice based on network pharmacology prediction. J. Int. Med. Res. 48(12):300060520951023(2020).
Verification of the Japanese staging system for rectal cancer, focusing on differences with the TNM classification.
Arabiki, M., Shimada, Y., Nakano, M., Tanaka, K., Oyanagi, H., Nakano, M., Ling, Y., Okuda, S., Takii, Y., Wakai, T. Verification of the Japanese staging system for rectal cancer, focusing on differences with the TNM classification. Surgery Today 50(11):1443-1451(2020).
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients.
Ohashi, R., Umezu, H., Sato, A., Abé, T., Kondo, S., Daigo, K., Sato, S., Hara, N., Miyashita, A., Ikeuchi, T., Motoyama, T., Kishi, M., Nagaoka, T., Horiuchi, K., Shiga, A., Okuda, S., Sekiya, T., Ohtsubo, A., Ichikawa, K., Kagamu, H., Kikuchi, T., Watanabe, S., Tanuma, J-I., Schraml, P., Hamakubo, T., Tsuchida, M., Ajioka, Y. Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients. Cells 9(11):2409(2020).
Genetic profiling for diffuse type and genomically stable subtypes in gastric cancer.
Ling, Y., Watanabe, Y., Nagahashi, M., Shimada, Y., Ichikawa, H., Wakai, T., Okuda, S. Genetic profiling for diffuse type and genomically stable subtypes in gastric cancer. Comput. Struct. Biotechnol. J. 18:3301-3308(2020).
Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection.
Hakamata, M., Takihara, H., Iwamoto, T., Tamaru, A., Hashimoto, A., Tanaka, T., Kaboso, S. A., Gebretsadik, G., Ilinov, A., Yokoyama, A., Ozeki, Y., Nishiyama, A., Tateishi, Y., Moro, H., Kikuchi, T., Okuda, S., Matsumoto, S. Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection. Sci. rep. 10(1):17997(2020).
Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics.
Yang, M., Petralia, F., Li, Z., Li, H., Ma, W., Song, X., Kim, S., Lee, H., Yu, H., Lee, B., Bae, S., Heo, E., Kaczmarczyk, J., Stępniak, P., Warchoł, M., Yu, T., Calinawan, A. P., Boutros, P. C., Payne, S. H., Reva, B.; NCI-CPTAC-DREAM Consortium, Boja, E., Rodriguez, H., Stolovitzky, G., Guan, Y., Kang, J., Wang, P., Fenyö, D., Saez-Rodriguez, J. Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics. Cell Systems 11(2):186-195.e9 (2020).
The GlyCosmos Portal: a unified and comprehensive web resource for the glycosciences.
Yamada, I., Shiota, M., Shinmachi, D., Ono, T., Tsuchiya, S., Hosoda, M., Fujita, A., Aoki, N. P., Watanabe, Y., Fujita, N., Angata, K., Kaji, H., Narimatsu, H., Okuda, S., Aoki-Kinoshita, K. F. The GlyCosmos Portal: a unified and comprehensive web resource for the glycosciences. Nat. Methods 17(7):649-650(2020).
Innate Immune Responses in Serum and Cerebrospinal Fluid From Neonates and Infants Infected With Parechovirus-A3 or Enteroviruses.
Habuka, R., Aizawa, Y., Izumita, R., Domon, H., Terao, Y., Takihara, H., Okuda, S., Saitoh, A. Innate Immune Responses in Serum and Cerebrospinal Fluid From Neonates and Infants Infected With Parechovirus-A3 or Enteroviruses. J. Infect. Dis. 222(4):681-689(2020).
RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
Matsumoto, A., Shimada, Y., Nakano, M., Oyanagi, H., Tajima, Y., Nakano, M., Kameyama, H., Hirose, Y., Ichikawa, H., Nagahashi, M., Nogami, H., Maruyama, S., Takii, Y., Ling, Y., Okuda, S., Wakai, T. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer. Oncol. Rep. 43(6):1853-1862(2020).